Long-term safety of Infliximab for the treatment of inflammatory bowel disease: Does blocking TNFα reduce colitis-associated colorectal carcinogenesis?

Onali S.;
2009-01-01
2009
antibodies monoclonal; cell transformation neoplastic; colorectal neoplasms; gastrointestinal agents; humans; inflammatory bowel diseases; infliximab; tumor necrosis factor-alpha
Files in This Item:
File Size Format  
Gut-2009-Biancone-1703.pdf

Solo gestori archivio

Size 95.81 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
95.81 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie